Patent Review (2017–2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases

Research on the antioxidant pathway comprising the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) and its cytoplasmic inhibitor Kelch-like ECH-associated protein 1 (Keap1) is ever increasing. As modulators of this pathway have started to be used in clinical trials and clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chartoumpekis, Dionysios V., Fu, Chun-Yan, Ziros, Panos G., Sykiotis, Gerasimos P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697445/
https://www.ncbi.nlm.nih.gov/pubmed/33212784
http://dx.doi.org/10.3390/antiox9111138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697445/
https://www.ncbi.nlm.nih.gov/pubmed/33212784
http://dx.doi.org/10.3390/antiox9111138

Ejemplares similares